Vivani Medical, Inc.
VANI
$1.33
-$0.03-1.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -10.54% | 3.72% | 1.07% | 4.75% | 24.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.88% | 3.97% | 5.42% | 6.59% | 31.35% |
| Operating Income | 7.88% | -3.97% | -5.42% | -6.59% | -31.35% |
| Income Before Tax | 10.83% | -7.58% | -9.64% | -8.09% | -33.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 10.83% | -7.58% | -9.64% | -8.09% | -33.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.83% | -7.58% | -9.64% | -8.09% | -33.38% |
| EBIT | 7.88% | -3.97% | -5.42% | -6.59% | -31.35% |
| EBITDA | 8.34% | -3.59% | -5.09% | -6.83% | -31.88% |
| EPS Basic | 39.39% | 21.62% | 11.76% | -0.09% | -23.95% |
| Normalized Basic EPS | 39.39% | 21.65% | 11.70% | -0.15% | -24.01% |
| EPS Diluted | 39.39% | 21.62% | -79.32% | -0.09% | -23.95% |
| Normalized Diluted EPS | 39.39% | 21.65% | 11.70% | -0.15% | -24.01% |
| Average Basic Shares Outstanding | 47.00% | 37.20% | 24.27% | 8.08% | 7.68% |
| Average Diluted Shares Outstanding | 47.00% | 37.20% | 24.27% | 8.08% | 7.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |